Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 500

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 500
---
 A member unit, basic and diluted                  | ​ | ​ | ​                                      | $ |      -0.02 | ​ | ​ | ​ | ​    | $ |      -0.03 | ​ | ​ |
| Net loss per Class B member unit, basic and diluted                  | ​ | ​ | ​                                      | $ |      -0.10 | ​ | ​ | ​ | ​    | $ |      -0.13 | ​ | ​ |
| Weighted average Class A member units outstanding, basic and diluted | ​ | ​ | ​                                      | ​ | 95,555,554 | ​ | ​ | ​ | ​    | ​ | 82,546,600 | ​ | ​ |
| Weighted average Class B member units outstanding, basic and diluted | ​ | ​ | ​                                      | ​ | 16,666,666 | ​ | ​ | ​ | ​    | ​ | 16,666,666 | ​ | ​ |

The accompanying notes are an integral part of these unaudited condensed financial statements. F-54

TABLE OF CONTENTS LIMINATUS PHARMA, LLC UNAUDITED CONDENSED STATEMENTS OF CHANGES IN MEMBERS’ DEFICIT
(in thousands, except member unit data)

| ​                                         | ​ | ​ | For the nine months ended September 30, 2024 |   |            |   |   |   |        |   |       |   |   |   |                      |   |            |   |   |   |        |   |     |   |   |   |                          |   |       |   |   |   |                    |   |         |   |   |   |                       |   |         |   | ​ |
|:------------------------------------------|:--|:--|:---------------------------------------------|:--|-----------:|:--|:--|:--|:-------|:--|------:|:--|:--|:--|:---------------------|:--|-----------:|:--|:--|:--|:-------|:--|----:|:--|:--|:--|:-------------------------|:--|------:|:--|:--|:--|:-------------------|:--|--------:|:--|:--|:--|:----------------------|:--|--------:|:--|:--|
| ​                                         | ​ | ​ | Class A Member Units